| Literature DB >> 32821507 |
Kaspar Schuerch1, Hendrik Frech1, Martin Zinkernagel1.
Abstract
Purpose: To detect and quantify conjunctival microangiopathy with optical coherence tomography angiography (OCTA).Entities:
Keywords: anterior segment optical coherence tomography; diabetes mellitus; diabetic retinopathy; optical coherence tomography angiography; scanning laser ophthalmoscope
Mesh:
Year: 2020 PMID: 32821507 PMCID: PMC7408868 DOI: 10.1167/tvst.9.6.10
Source DB: PubMed Journal: Transl Vis Sci Technol ISSN: 2164-2591 Impact factor: 3.283
Figure 1.Assessment of conjunctival vessels using anterior OCTA. (A) En face OCT of the temporal quadrant of a right eye corresponding to the conjunctival slab in B. Green and blue arrows refer to the position of the OCT scan. (B) OCT image in the position of the green arrow in A. The two red dotted lines show the depth of the OCTA slab (100 µm depth, 50 µm thickness). (C) En face OCTA revealing the vascular meshwork of the conjunctival slab. (D) OCTA scan in the position of the green arrow in A. The two red dotted lines show the depth of the OCTA slab (100 µm depth, 50 µm thickness). The reflectivity of vessels is shown in yellow within the OCT scan.
Figure. 2.OCTA imaging of conjunctival vessels in healthy subjects (patient 69 [P69]), patients with diabetes without retinopathy (patient 73 [P73]) and patients with DR (patients 4 and 78 [P4, P78]). (A) Top row showing optical coherence tomography (OCT) scans with the corresponding angiography slabs (dotted red lines with transparent red) chosen at 100 µm depth, 50 µm thickness and corresponding en face OCTA images (B). (C) Binary image after standardization of the brightest vessels. The rim of the limbal vessels is demarcated with a red line. Red squares show the measured ROI.
Baseline Characteristics
|
| Age, Years (Range) | Male ( | Female ( | |
|---|---|---|---|---|
| Total included individuals | 74 | 47.82 (20–87) | 41 | 33 |
| Healthy individuals | 42 | 39.38 (20–77) | 23 | 19 |
| DM without RP | 9 | 64.11(43–81) | 5 | 4 |
| DM with RP | 23 | 58.13 (22–87) | 13 | 11 |
DM, diabetes mellitus; RP, retinopathy.
Figure. 3.Box and whisker plots (minimum to maximum) plot of the relative vessel density score. The relative vessel density score is given in arbitrary units. Box and whiskers plots for the temporal (A) and nasal (B) measurements. There was a statistical difference in vessel density between group 1 and group 3 for the temporal (P = 0.0386), as well as the nasal (P = 0.0103) side (*). (Healthy, n = 42; diabetes mellitus without retinopathy [DM without RP], n = 9; diabetes mellitus with retinopathy [DM with RP], n = 23; NPDR, nonproliferative DR; PDR, proliferative DR).
Vessel Densities Score and P Values
| Temporal | Nasal | |||||
|---|---|---|---|---|---|---|
| Vessel Density Score |
| Average | SD |
| Average | SD |
| Group 1: Healthy | 74 | 17.9 | 6.4 | 75 | 16.7 | 5.2 |
| Group 2: DM without RP | 12 | 15.3 | 7.3 | 11 | 16.3 | 6.7 |
| Group 3: DM with RP | 36 | 15.2 | 6.5 | 26 | 13.7 | 4.3 |
| Temporal | Nasal | |||||
| Group 1 vs. group 2 | 0.1942 | 0.8043 | ||||
| Group 2 vs. group 3 | 0.9737 | 0.1744 | ||||
| Group 1 vs. group 3 | 0.0386 | 0.0103 | ||||
Vessel density scores are given in arbitrary units. Healthy = group 1; DM without RP = group 2; DM with RP = group 3. P values of unpaired t-test between all groups group are listed below. DM, diabetes mellitus; RP, retinopathy; SD, standard deviation.